Literature DB >> 11079501

Effects of 90Y-microspheres on liver tumors: comparison of intratumoral injection method and intra-arterial injection method.

W Y Lin1, S C Tsai, J F Hsieh, S J Wang.   

Abstract

UNLABELLED: Internal radiation therapy using intrahepatic arterial injection of 90Y-labeled glass microspheres (90Y-microspheres) has proven to be a promising therapeutic modality for inoperative liver tumor. Recently, direct intratumoral injection of 90Y-microspheres has been performed with even more encouraging results. The purpose of this study was to compare the treatment efficacy of these 2 methods using 90Y-microspheres.
METHODS: Forty-eight male rats, each bearing a hepatic tumor, were divided into 4 groups (12 rats in each group) to evaluate the efficacy of treatment. Group 1 received an intratumoral injection of 37 MBq (1 mCi) 90Y-microspheres. Group 2 received an intratumoral injection of 0.1 mL normal saline as the control group. Group 3 received an intra-arterial injection of 37 MBq (1 mCi) 90Y-microspheres. Group 4 received an intra-arterial injection of 0.1 mL normal saline as the control group. Tumor size was measured by liver sonography before injection as well as at 2 and 4 wk after injection. Survival time was calculated from the day of treatment to 2 mo after treatment by Kaplan-Meier survival analysis. The response rate was evaluated by the change in tumor size and survival time. Fisher's exact, 2-tailed test was used to compare response rates.
RESULTS: In the rats treated by intratumoral injection of 90-Y-microspheres, 83.3% (10/12) showed a good response. In contrast, all 12 rats in the control group showed a poor response. The difference was significant (P < 0.00001). Eighty-three percent (10/12) of the rats survived >60 d after intratumoral injection of 90Y-microspheres, whereas only 25% (3/12) of the control rats survived >60 d. The difference was significant (P = 0.0068). In the rats treated by intra-arterial injection of 90Y-microspheres, 58.3% (7/12) showed a good response to the treatment. All rats in the control group showed a poor response. The difference was significant (P = 0.0023). Sixty-six percent (8/12) of the rats survived >60 d after intra-arterial injection of 90Y-microspheres, whereas only 16.7% (2/12) of the control rats survived >60 d. The difference was significant (P = 0.0385). However, the response rate and survival time between the intratumoral treatment group and the intra-arterial treatment group showed no significant difference (P = 0.3707 and 0.3988, respectively).
CONCLUSION: Both methods (intratumoral treatment and intraarterial treatment) showed a significantly good response rate and prolonged survival time compared with those of the control groups. However, no significant difference was found in the response rate or survival time between intratumoral treatment and intra-arterial treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079501

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations.

Authors:  Scott M Thompson; Matthew R Callstrom; Bruce Knudsen; Jill L Anderson; Rickey E Carter; Joseph P Grande; Lewis R Roberts; David A Woodrum
Journal:  J Vasc Interv Radiol       Date:  2012-01-20       Impact factor: 3.464

2.  Biodistribution and excretion of radioactivity after the administration of 166Ho-chitosan complex (DW-166HC) into the prostate of rat.

Authors:  Seung Kyoo Seong; Jei Man Ryu; Dong Hyuk Shin; Eun Jeong Bae; Akiyo Shigematsu; Yasuhiko Hatori; Junko Nishigaki; Cheol Kwak; Sang Eun Lee; Kyong Bae Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-20       Impact factor: 9.236

3.  Preparation and complex characterization of silica holmium sol-gel monoliths.

Authors:  D Cacaina; S Areva; H Laaksonen; S Simon; H Ylänen
Journal:  J Mater Sci Mater Med       Date:  2010-12-05       Impact factor: 3.896

4.  Liver cancer targeting of Doxorubicin with reduced distribution to the heart using hematoporphyrin-modified albumin nanoparticles in rats.

Authors:  Ji-Eun Chang; Won-Sik Shim; Su-Geun Yang; Eun-Young Kwak; Saeho Chong; Dae-Duk Kim; Suk-Jae Chung; Chang-Koo Shim
Journal:  Pharm Res       Date:  2011-10-05       Impact factor: 4.200

5.  AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry.

Authors:  Scott M Thompson; Matthew R Callstrom; Bruce Knudsen; Jill L Anderson; Kim A Butters; Joseph P Grande; Lewis R Roberts; David A Woodrum
Journal:  Cardiovasc Intervent Radiol       Date:  2012-08-25       Impact factor: 2.740

6.  Biodistribution, Pharmacokinetics and Efficacy of 188Re(I)-Tricarbonyl-Labeled Human Serum Albumin Microspheres in an Orthotopic Hepatoma Rat Model.

Authors:  Liang-Cheng Chen; Wan-Chi Lee; Chung-Li Ho; Ya-Jen Chang; Su-Jung Chen; Chih-Hsien Chang
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

7.  Microspheres with ultrahigh holmium content for radioablation of malignancies.

Authors:  W Bult; P R Seevinck; G C Krijger; T Visser; L M J Kroon-Batenburg; C J G Bakker; W E Hennink; A D van het Schip; J F W Nijsen
Journal:  Pharm Res       Date:  2009-02-25       Impact factor: 4.200

8.  Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.

Authors:  Sibu P Kuruvilla; Gopinath Tiruchinapally; A Colleen Crouch; Mohamed E H ElSayed; Joan M Greve
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

9.  Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.

Authors:  Wouter Bult; Stephanie G C Kroeze; Mattijs Elschot; Peter R Seevinck; Freek J Beekman; Hugo W A M de Jong; Donald R A Uges; Jos G W Kosterink; Peter R Luijten; Wim E Hennink; Alfred D van het Schip; J L H Ruud Bosch; J Frank W Nijsen; Judith J M Jans
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

Review 10.  Intratumoral treatment with radioactive beta-emitting microparticles: a systematic review.

Authors:  Robbert C Bakker; Marnix G E H Lam; Sebastiaan A van Nimwegen; Antoine J W P Rosenberg; Robert J J van Es; J Frank W Nijsen
Journal:  J Radiat Oncol       Date:  2017-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.